Cargando…
Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
While sarcomas account for approximately 1% of malignant tumors of adults, they are particularly more common in children and adolescents affected by cancer. In contrast to malignancies that occur in later stages of life, childhood tumors, including sarcoma, are characterized by a striking paucity of...
Autores principales: | Knott, Maximilian M. L., Hölting, Tilman L. B., Ohmura, Shunya, Kirchner, Thomas, Cidre-Aranaz, Florencia, Grünewald, Thomas G. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994515/ https://www.ncbi.nlm.nih.gov/pubmed/31970591 http://dx.doi.org/10.1007/s10555-019-09839-9 |
Ejemplares similares
-
Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
por: Hölting, Tilman L. B., et al.
Publicado: (2022) -
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
por: Ohmura, Shunya, et al.
Publicado: (2021) -
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
por: Dallmayer, Marlene, et al.
Publicado: (2019) -
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
por: Marchetto, Aruna, et al.
Publicado: (2020) -
Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
por: Marchetto, Aruna, et al.
Publicado: (2020)